On Monday, Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) was -3.36% down from the session before settling in for the closing price of $1.19. A 52-week
Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) on Monday, plunged -3.36% from the previous trading day, before settling in for the closing price of $1.19. Within
On Monday, Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) was 6.98% up from the session before settling in for the closing price of $1.08. A 52-week
Witnessing the stock’s movement on the chart, on Wednesday Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) had a quiet start as it plunged -5.26% to $1.08,
Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) on Friday, soared 8.72% from the previous trading day, before settling in for the closing price of $0.90. Within
As on Wednesday, Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) started slowly as it slid -4.17% to $0.99, before settling in for the price of $1.03
Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) kicked off on Friday, down -10.08% from the previous trading day, before settling in for the closing price of
On Tuesday, Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) opened higher 0.74% from the last session ,before settling in for the closing price of $1.36. Price
Witnessing the stock’s movement on the chart, on May 24, 2023, Adaptimmune Therapeutics plc (NASDAQ: ADAP) had a quiet start as it plunged -1.64% to
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
